Evidence map›Paper›PMID 31690312›Full record

Trial reportBMC surgery2019

Omentopexy with Glubran®2 for reducing complications after laparoscopic sleeve gastrectomy: results of a randomized controlled study.

Vincenzo Pilone, Salvatore Tramontano, Michele Renzulli, Mafalda Romano, Angela Monda, Alice Albanese, Mirto Foletto

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03833232 (Omentopexy With Glubran®2 for Reducing Complications After Laparoscopic Sleeve Gastrectomy), which is not on this map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03833232 phase4completednot on this map

Omentopexy With Glubran®2 for Reducing Complications After Laparoscopic Sleeve Gastrectomy: Results of a Prospective Study.

TypeinterventionalSponsorUniversity of SalernoRan2017 to 2017Enrolled90ConditionsObesity With BMI >35Armsomentopexy with cyanoacrilate glue
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. ARE THERE BENEFITS IN PERFORMING GASTRO-OMENTOPEXY IN LAPAROSCOPIC VERTICAL GASTRECTOMY?Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2022
    Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vincenzo PiloneGeneral, Bariatric and Emergency Surgery Unit of Fucito Hospital, University Hospital of Salerno, Salerno, Italy.
Salvatore TramontanoGeneral, Bariatric and Emergency Surgery Unit of Fucito Hospital, University Hospital of Salerno, Salerno, Italy. salvytra@libero.it.ORCID http://orcid.org/0000-0001-9714-1763
Michele RenzulliGeneral, Bariatric and Emergency Surgery Unit of Fucito Hospital, University Hospital of Salerno, Salerno, Italy.
Mafalda RomanoGeneral, Bariatric and Emergency Surgery Unit of Fucito Hospital, University Hospital of Salerno, Salerno, Italy.
Angela MondaGeneral, Bariatric and Emergency Surgery Unit of Fucito Hospital, University Hospital of Salerno, Salerno, Italy.
Alice AlbaneseWeek Surgery Unit, University Hospital of Padova, Padova, Italy.
Mirto FolettoWeek Surgery Unit, University Hospital of Padova, Padova, Italy.
University of Salerno · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric fistulas, bleeding, and strictures are commonly reported after laparoscopic sleeve gastrectomy (LSG), that increase morbidity and hospital stay and may put the patient's life at risk. We report our prospective evaluation of application of synthetic sealant, a modified cyanoacrylate (Glubran®2), on suture rime, associated with omentopexy, to identify results on LSG-related complications.

methodsPatients were enrolled for LSG by two Bariatric Centers, with high-level activity volume. Intraoperative recorded parameters were: operative time, estimated intraoperative bleeding, conversion rate. We prospectively evaluated the presence of early complications after LSG during the follow up period. Overall complications were analyzed. Perioperative data and weight loss were also evaluated. A control group was identified for the study.

resultsGroup A (treated with omentopexy with Glubran®2) included 96 cases. Control group included 90 consecutive patients. There were no differences among group in terms of age, sex and Body Mass Index (BMI). No patient was lost to follow-up for both groups. Overall complication rate was significantly reduced in Group A. Mean operative time and estimated bleeding did not differ from control group. We observed three postoperative leaks in Group B, while no case in Group A (not statistical significancy). We did not observe any mortality, neither reoperation. Weight loss of the cohort was similar among groups. In our series, no leaks occurred applying omentopexy with Glubran®2.

conclusionOur experience of omentopexy with a modified cyanoacrylate sealant may lead to a standardized and reproducible approach that can be safeguard for long LSG-suture rime.

trial registrationRetrospective registration on clinicaltrials.gov PRS, with TRN NCT03833232 (14/02/2019).

Indexed as

Administration, TopicalAdultAnastomotic LeakCyanoacrylatesFemaleGastrectomyHumansLaparoscopyMaleObesity, MorbidOmentumProspective StudiesTissue AdhesivesTreatment OutcomeCyanoacrylatesglubranTissue AdhesivesGastric fistulaLeakOmentopexySealantSleeve gastrectomy

Identifiers

PMID31690312
PMCPMC6829794
OpenAlexW2988078778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.